Defence Therapeutics Inc. (FRA:DTC)
Germany · Delayed Price · Currency is EUR 0.4200
-0.0010 (-0.24%)
At close: Dec 30, 2025
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of €24.14 million as of January 9, 2026. Its market cap has increased by 32.08% in one year.
Market Cap
24.14M
Enterprise Value
24.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.42
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 60.36M to 24.14M, a decrease of -60.02%. That is a compound annual growth rate of -17.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 24.14M | -5.94% |
| Dec 31, 2025 | 25.66M | 21.41% |
| Dec 31, 2024 | 21.13M | -70.23% |
| Dec 29, 2023 | 70.98M | 4.33% |
| Dec 30, 2022 | 68.04M | -49.69% |
| Dec 31, 2021 | 135.24M | 124.04% |
| May 7, 2021 | 60.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |